Burke Thomas Barrett - 12 May 2024 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role
President and CEO, Director
Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
Issuer symbol
PLSE
Transactions as of
12 May 2024
Net transactions value
$0
Form type
4
Filing time
24 Jun 2024, 19:31:51 UTC
Next filing
22 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLSE Stock Option (right to buy) Award $0 +700,000 $0.000000 700,000 12 May 2024 Common Stock 700,000 $7.45 Direct F1
transaction PLSE Stock Option (right to buy) Award $0 +700,000 $0.000000 700,000 12 May 2024 Common Stock 700,000 $7.45 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares will vest in four equal annual installments on each of the first four annual anniversaries of the grant date, subject to the Reporting Person's continued service through each vesting date.
F2 The shares subject to this option are subject to five tranches of performance-based vesting criteria tied to Issuer's market capitalization, with no vesting until the Issuer's market capitalization exceeds $1 billion, in all cases, subject to the Reporting Person's continued service through each vesting milestone.